Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: A target molecule for lung cancer therapy

Pharmacological Research

Volumn 76, Issue , 2013, Pages 119-131

  Inazu, Masato ^a   Yamada, Tomoko ^a   Kubota, Nobuo ^b   Yamanaka, Tsuyoshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b POLA PHARMA INC   (Japan)

Author keywords

Acetylcholine; Apoptosis; Cell proliferation; Choline; Small cell lung carcinoma; Transporter

Indexed keywords

4 AMINOHIPPURIC ACID; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; 5 (N,N DIMETHYL)AMILORIDE; ACETYLCHOLINE; CARRIER PROTEIN; CASPASE 3; CASPASE 7; CATION; CHOLINE TRANSPORTER 1; CHOLINE TRANSPORTER LIKE PROTEIN 1; HEMICHOLINIUM 3; MESSENGER RNA; ORGANIC CATION TRANSPORTER 1; ORGANIC CATION TRANSPORTER 2; ORGANIC CATION TRANSPORTER 3; PHYSOSTIGMINE; PROFENAMINE; SMALL INTERFERING RNA; SODIUM ION; SODIUM PROTON EXCHANGE PROTEIN 1; SODIUM PROTON EXCHANGE PROTEIN 2; SODIUM PROTON EXCHANGE PROTEIN 3; SODIUM PROTON EXCHANGE PROTEIN 4; SODIUM PROTON EXCHANGE PROTEIN 5; UNCLASSIFIED DRUG;

ACETYLCHOLINE RELEASE; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CELL PH; CELL PROLIFERATION; CELL VIABILITY; CHOLINE UPTAKE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LUNG SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

2-(N-MORPHOLINO)ETHANESULFONIC ACID; 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL; 4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID; 4-DAMP; 4-DIPHENYLACETOXY-N-METHYLPIPERIDINE METHIODIDE; 4′,6-DIAMIDINO-2-PHENYLINDOLE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ACH; ACHE; APOPTOSIS; BUCHE; BUTYRYLCHOLINESTERASE; CELL PROLIFERATION; CHAT; CHOLINE; CHOLINE ACETYLTRANSFERASE; CHOLINE TRANSPORTER-LIKE PROTEIN 1; CHT1; CTL1; D-PBS; DAPI; DFP; DIISOPROPYL FLUOROPHOSPHATES; DIMETHYLAMILORIDE; DMA; DULBECCO'S PHOSPHATE-BUFFERED SALINE; GAPDH; GLYCERALDEHYDES-3-PHOSPHATE DEHYDROGENASE; HC-3; HEMICHOLINIUM-3; HEPES; HIGH-AFFINITY CHOLINE TRANSPORTER 1; MACHR3; MES; MUSCARINIC CHOLINERGIC RECEPTOR 3; N-METHYL-D-GLUCAMINE; NA(+)/H(+) EXCHANGER; NHE; NMDG; OCT; ORGANIC CATION TRANSPORTER; P-AMINOHIPPURIC ACID; PAH; PCHO; PET; PHOSPHOCHOLINE; POSITRON EMISSION TOMOGRAPHY; SCLC; SELECTIVE SEROTONIN REUPTAKE INHIBITOR; SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITOR; SIRNA; SMALL CELL LUNG CARCINOMA; SMALL INTERFERING RNA; SNRI; SSRI; TCA; TEA; TETRAETHYLAMMONIUM CHLORIDE; TRANSPORTER; TRICYCLIC ANTIDEPRESSANT; TRIS; VACHT; VESICULAR ACETYLCHOLINE TRANSPORTER;

ACETYLCHOLINE; ANTIGENS, CD; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL SURVIVAL; CHOLINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MOLECULAR TARGETED THERAPY; ORGANIC CATION TRANSPORT PROTEINS; RNA, SMALL INTERFERING; SMALL CELL LUNG CARCINOMA;

EID: 84883173149     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.07.011     Document Type: Article

References (59)

1. L.G. Collins, C. Haines, R. Perkel, and R.E. Enck Lung cancer: diagnosis and management Am Fam Physician 75 2007 56 63
2. J.P. Wisnivesky, E.A. Halm, M. Bonomi, C. Smith, G. Mhango, and E. Bagiella Postoperative radiotherapy for elderly patients with stage III lung cancer Cancer 118 2012 4478 4485
3. P. Russo, A. Catassi, A. Cesario, and D. Servent Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system Curr Med Chem 13 2006 3493 3512
4. P. Song, H.S. Sekhon, Y. Jia, J.A. Keller, J.K. Blusztajn, and G.P. Mark Acetylcholine is synthesized by and acts as an autocrine growth factor for small cell lung carcinoma Cancer Res 63 2003 214 221
5. P. Song, H.S. Sekhon, A. Lu, J. Arredondo, D. Sauer, and C. Gravett M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion Cancer Res 67 2007 3936 3944
6. S. Zhang, S. Togo, K. Minakata, T. Gu, R. Ohashi, and K. Tajima Distinct roles of cholinergic receptors in small cell lung cancer cells Anticancer Res 30 2010 97 106
7. J. Klein, R. Gonzalez, A. Köppen, and K. Löffelholz Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain Neurochem Int 22 1993 293 300
8. S. Apparsundaram, S.M. Ferguson, A.L. George Jr., and R.D. Blakely Molecular cloning of a human, hemicholinium-3-sensitive choline transporter Biochem Biophys Res Commun 276 2000 862 867
9. T. Okuda, T. Haga, Y. Kanai, H. Endou, T. Ishihara, and I. Katsura Identification and characterization of the high-affinity choline transporter Nat Neurosci 3 2000 120 125
10. G. Burckhardt, and N.A. Wolff Structure of renal organic anion and cation transporters Am J Physiol Renal Physiol 278 2000 F853 F866
11. H. Koepsell, K. Lips, and C. Volk Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications Pharm Res 24 2007 1227 1251
12. V. Gorboulev, J.C. Ulzheimer, A. Akhoundova, I. Ulzheimer-Teuber, U. Karbach, and S. Quester Cloning and characterization of two human polyspecific organic cation transporters DNA Cell Biol 16 1997 871 881
13. D. Gründemann, B. Schechinger, G.A. Rappold, and E. Schömig Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter Nat Neurosci 1 1998 349 351
14. D. Gründemann, G. Liebich, N. Kiefer, S. Köster, and E. Schömig Selective substrates for non-neuronal monoamine transporters Mol Pharmacol 56 1999 1 10
15. R. Kekuda, P.D. Prasad, X. Wu, H. Wang, Y.J. Fei, and F.H. Leibach Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta J Biol Chem 273 1998 15971 15979
16. X. Wu, R. Kekuda, W. Huang, Y.J. Fei, F.H. Leibach, and J. Chen Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain J Biol Chem 273 1998 32776 32786
17. S. O'Regan, E. Traiffort, M. Ruat, N. Cha, D. Compaore, and F.M. Meunier An electric lobe suppressor for a yeast choline transport mutation belongs to a new family of transporter-like proteins Proc Natl Acad Sci USA 97 2000 1835 1840
18. S. O'Regan, and F.M. Meunier Selection and characterization of the choline transport mutation suppressor from Torpedo electric lobe, CTL1 Neurochem Res 28 2003 551 555
19. +-independent choline transporter in rat astrocytes J Neurochem 94 2005 1427 1437
20. Y. Uchida, M. Inazu, H. Takeda, T. Yamada, H. Tajima, and T. Matsumiya Expression and functional characterization of choline transporter in human keratinocytes J Pharm Sci 109 2009 102 109
21. H. Kouji, M. Inazu, T. Yamada, H. Tajima, T. Aoki, and T. Matsumiya Molecular and functional characterization of choline transporter in human colon carcinoma HT-29 cells Arch Biochem Biophys 483 2009 90 98
22. M. Yabuki, M. Inazu, T. Yamada, H. Tajima, and T. Matsumiya Molecular and functional characterization of choline transporter in rat renal tubule epithelial NRK-52E cells Arch Biochem Biophys 485 2009 88 96
23. T.S. Nair, K.E. Kozma, N.L. Hoefling, P.K. Kommareddi, Y. Ueda, and T.W. Gong Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss J Neurosci 24 2004 1772 1779
24. T. Nakamura, R. Fujiwara, N. Ishiguro, M. Oyabu, T. Nakanishi, and Y. Shirasaka Involvement of choline transporter-like proteins, CTL1 and CTL2, in glucocorticoid-induced acceleration of phosphatidylcholine synthesis via increased choline uptake Biol Pharm Bull 33 2010 691 696
25. P.K. Kommareddi, T.S. Nair, L.V. Thang, M.M. Galano, E. Babu, and V. Ganapathy expression, glycosylation, and tissue distribution of CTL2/SLC44A2 Protein J 29 2010 417 426
26. R. Katz-Brull, and H. Degani Kinetics of choline transport and phosphorylation in human breast cancer cells; NMR application of the zero trans method Anticancer Res 16 1996 1375 1380
27. K. Glunde, and N.J. Serkova Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism Pharmacogenomics 7 2006 1109 1123
28. H. Cai, P. Erhardt, J. Troppmair, M.T. Diaz-Meco, G. Sithanandam, and U.R. Rapp Hydrolysis of phosphatidylcholine couples Ras to activation of Raf protein kinase during mitogenic signal transduction Mol Cell Biol 13 1993 7645 7651
29. W. Möller-Hartmann, S. Herminghaus, T. Krings, G. Marquardt, H. Lanfermann, and U. Pilatus Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions Neuroradiology 44 2002 371 381
30. R.J. Gillies, and D.L. Morse In vivo magnetic resonance spectroscopy in cancer Annu Rev Biomed Eng 7 2005 287 326
31. K. Glunde, L. Jiang, S.A. Moestue, and I.S. Gribbestad Magnetic Resonance Spectroscopy and Imaging Guidance in Molecular Medicine: Targeting and Monitoring of Choline and Glucose Metabolism in Cancer NMR Biomed 24 2011 673 690
32. S.A. Kwee, H. Wei, I. Sesterhenn, D. Yun, and M.N. Coel Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET J Nucl Med 47 2006 262 269
33. 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas J Neurosurg 99 2003 474 479
34. K. Glunde, C. Jie, and Z.M. Bhujwalla Molecular causes of the aberrant choline phospholipid metabolism in breast cancer Cancer Res 64 2004 4270 4276
35. K. Glunde, M.A. Jacobs, and Z.M. Bhujwalla Choline metabolism in cancer: implications for diagnosis and therapy Expert Rev Mol Diagn 6 2006 821 829
36. G. Eliyahu, T. Kreizman, and H. Degani Phosphocholine as a biomarker of breast cancer: molecular and biochemical studies Int J Cancer 120 2007 1721 1730
37. 11C]choline J Nucl Med 38 1997 842 847
38. T. Hara, N. Kosaka, and H. Kishi PET imaging of prostate cancer using carbon-11-choline J Nucl Med 39 1998 990 995
39. 11C-choline PET J Nucl Med 41 2000 1507 1513
40. 18F-fluorodeoxyglucose: a novel method of preoperative lymph node staging Cancer 86 1999 1638 1648
41. T. Yamada, M. Inazu, H. Tajima, and T. Matsumiya Functional expression of choline transporter-like protein 1 (CTL1) in human neuroblastoma cells and its link to acetylcholine synthesis Neurochem Int 58 2011 354 365
42. 50) of an enzymatic reaction Biochem Pharmacol 22 1973 3099 3108
43. E. Ackerstaff, K. Glunde, and Z.M. Bhujwalla Choline phospholipid metabolism: a target in cancer cells J Cell Biochem 90 2003 525 533
44. A. Ramírez de Molina, A. Rodríguez-González, V. Penalva, L. Lucas, and J.C. Lacal Inhibition of ChoK is an efficient antitumor strategy for Harvey-, Kirsten-, and N-ras-transformed cells Biochem Biophys Res Commun 285 2001 873 879
45. S. Janardhan, P. Srivani, and G.N. Sastry Choline kinase: an important target for cancer Curr Med Chem 13 2006 1169 1186
46. D. Gallego-Ortega, T. Gómez del Pulgar, F. Valdés-Mora, A. Cebrián, and J.C. Lacal Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions Adv Enzyme Regul 51 2011 183 194
47. H. Koepsell, and H. Endou The SLC22 drug transporter family Pflugers Arch 447 2004 666 676
48. E. Traiffort, M. Ruat, S. O'Regan, and F.M. Meunier Molecular characterization of the family of choline transporter-like proteins and their splice variants J Neurochem 92 2005 1116 1125
49. +-independent choline transport in primary cultures of neurons from mouse cerebral cortex Neurosci Lett 393 2006 216 221
50. T. Wang, J. Li, F. Chen, Y. Zhao, X. He, and D. Wan Choline transporters in human lung adenocarcinoma: expression and functional implications Acta Biochim Biophys Sin (Shanghai) 39 2007 668 674
51. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes FASEB J 14 2000 2185 2197
52. + exchanger in metastasis Nat Rev Cancer 5 2005 786 795
53. + antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin - one single nature Biochim Biophys Acta 1756 2005 1 24
54. C.D. Albright, R. Liu, T.C. Bethea, K.A. Da Costa, R.I. Salganik, and S.H. Zeisel Choline deficiency induces apoptosis in SV40-immortalized CWSV-1 rat hepatocytes in culture FASEB J 10 1996 510 516
55. S.H. Zeisel, C.D. Albright, O.H. Shin, M.H. Mar, R.I. Salganik, and K.A. Da Costa Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes Carcinogenesis 18 1997 731 738
56. D. Gallego-Ortega, A. Ramirez de Molina, M.A. Ramos, F. Valdes-Mora, M.G. Barderas, and J. Sarmentero-Estrada Differential role of human choline kinase alpha and beta enzymes in lipid metabolism: implications in cancer onset and treatment PLoS One 4 2009 e7819
57. K. Glunde, Z.M. Bhujwalla, and S.M. Ronen Choline metabolism in malignant transformation Nat Rev Cancer 11 2011 835 848
58. P. Song, and E.R. Spindel Basic and clinical aspects of non-neuronal acetylcholine: expression of non-neuronal acetylcholine in lung cancer provides a new target for cancer therapy J Pharm Sci 106 2008 180 185
59. E.R. Spindel Muscarinic receptor agonists and antagonists: effects on cancer Handb Exp Pharmacol 208 2012 451 468